Liquid biopsies in gastrointestinal malignancies: when is the big day?. Issue 1 (2nd January 2018)
- Record Type:
- Journal Article
- Title:
- Liquid biopsies in gastrointestinal malignancies: when is the big day?. Issue 1 (2nd January 2018)
- Main Title:
- Liquid biopsies in gastrointestinal malignancies: when is the big day?
- Authors:
- Lopez, Anthony
Harada, Kazuto
Mizrak Kaya, Dilsa
Dong, Xiaochuan
Song, Shumei
Ajani, Jaffer A. - Abstract:
- ABSTRACT: Introduction : Tumor tissue sample is currently the gold standard for diagnosing gastrointestinal cancers, but also for genomic/immune component analyses that can help in the selection of therapy. However, this approach of studying a 'representative' sample of the tumor does not address inherent heterogeneity. Liquid biopsies, mainly represented by circulating tumor cells, circulating tumor DNA, tumor exosomes, and microRNAs, have the potential to assess various biomarkers for early detection of cancer, carrying out genomic/immune profiling for not only selection of appropriate therapy but also to monitor effect of therapy. Areas covered : This review summarizes the current evidence in the literature on liquid biopsies in gastrointestinal cancers concerning diagnosis, prognosis, and response to therapy. The following terms were used in PubMed: 'esophageal', 'gastric', 'colorectal', 'cancer', 'circulating tumor cells', 'circulating tumor DNA', microRNA', 'diagnosis', 'prognosis', 'response', 'resistance'. Expert commentary : Data increasingly supports the potential of liquid biopsies for early detection, selection of therapy, and monitoring response to therapy. One major question is whether assaying various components of the blood would accommodate considerable context-dependent heterogeneity of gastrointestinal tumors. There are many potential strategies to exploit liquid biopsy use. To put them in to perspective, well-designed and meticulous prospective studiesABSTRACT: Introduction : Tumor tissue sample is currently the gold standard for diagnosing gastrointestinal cancers, but also for genomic/immune component analyses that can help in the selection of therapy. However, this approach of studying a 'representative' sample of the tumor does not address inherent heterogeneity. Liquid biopsies, mainly represented by circulating tumor cells, circulating tumor DNA, tumor exosomes, and microRNAs, have the potential to assess various biomarkers for early detection of cancer, carrying out genomic/immune profiling for not only selection of appropriate therapy but also to monitor effect of therapy. Areas covered : This review summarizes the current evidence in the literature on liquid biopsies in gastrointestinal cancers concerning diagnosis, prognosis, and response to therapy. The following terms were used in PubMed: 'esophageal', 'gastric', 'colorectal', 'cancer', 'circulating tumor cells', 'circulating tumor DNA', microRNA', 'diagnosis', 'prognosis', 'response', 'resistance'. Expert commentary : Data increasingly supports the potential of liquid biopsies for early detection, selection of therapy, and monitoring response to therapy. One major question is whether assaying various components of the blood would accommodate considerable context-dependent heterogeneity of gastrointestinal tumors. There are many potential strategies to exploit liquid biopsy use. To put them in to perspective, well-designed and meticulous prospective studies will be needed to prove their usefulness. … (more)
- Is Part Of:
- Expert review of anticancer therapy. Volume 18:Issue 1(2018)
- Journal:
- Expert review of anticancer therapy
- Issue:
- Volume 18:Issue 1(2018)
- Issue Display:
- Volume 18, Issue 1 (2018)
- Year:
- 2018
- Volume:
- 18
- Issue:
- 1
- Issue Sort Value:
- 2018-0018-0001-0000
- Page Start:
- 19
- Page End:
- 38
- Publication Date:
- 2018-01-02
- Subjects:
- Cancer -- circulating tumor cells -- circulating tumor DNA -- colon -- esophagus -- microRNA -- stomach
Cancer -- Treatment -- Periodicals
616.99406 - Journal URLs:
- http://informahealthcare.com ↗
http://www.future-drugs.com/loi/era ↗ - DOI:
- 10.1080/14737140.2018.1403320 ↗
- Languages:
- English
- ISSNs:
- 1473-7140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002982
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 5530.xml